Literature DB >> 4608321

Studies on mediator production by highly purified human T and B lymphocytes.

R E Rocklin, R P MacDermott, L Chess, S F Schlossman, J R David.   

Abstract

Highly purified populations of T and B lymphocytes obtained by affinity column separation were stimulated by antigen and their ability to produce two mediators, migration inhibitory factor (MIF) and lymphocyte mitogenic factor (LMF) was assessed. Both T- and B-cell populations made MIF; the production of MIF was antigen-specific using purified protein derivative of tuberculin, streptokinase-streptodornase, and Candida antigens. The MIF activity from both populations could not be attributed to antigen-antibody complexes as the inhibitory activity eluted from Sephadex G-100 columns in the same region corresponding to mol wt 23,000 daltons. Further studies indicate that the T cells producing MIF are proliferating cells whereas the B cells producing this mediator are not. In contrast, LMF was made only by T cells and not B cells when these populations were stimulated by antigen. The LMF induced the [(3)H]thymidine incorporation into both T and B cells obtained from donors lacking sensitivity to the antigens used to elicit the factor. Chromatographic studies indicate that LMF eluted from Sephadex G-100 in a fraction of mol wt 23,000 daltons where MIF is also found; however, since B cells produce MIF but not LMF, these two factors appear to be distinct from one another. Some of the implications of these findings are discussed. The explanation for the production or lack of production of MIF by lymphocytes obtained from patients with immunodeficiency disorders requires reinterpretation.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4608321      PMCID: PMC2139736          DOI: 10.1084/jem.140.5.1303

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

Review 1.  Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators.

Authors:  J R David; R R David
Journal:  Prog Allergy       Date:  1972

Review 2.  Chronic mucocutaneous candidiasis: model-building in cellular immunity.

Authors:  C H Kirkpatrick; R R Rich; J E Bennett
Journal:  Ann Intern Med       Date:  1971-06       Impact factor: 25.391

3.  An in vitro assay for cellular hypersensitivity in man.

Authors:  R E Rocklin; O L Meyers; J R David
Journal:  J Immunol       Date:  1970-01       Impact factor: 5.422

4.  In vitro lymphocyte response of patients with immunologic deficiency diseases.

Authors:  R E Rocklin; F S Rosen; J R David
Journal:  N Engl J Med       Date:  1970-06-11       Impact factor: 91.245

5.  Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro.

Authors:  R E Rocklin; R A Chilgren; R Hong; J R David
Journal:  Cell Immunol       Date:  1970-09       Impact factor: 4.868

6.  Lymphocyte stimulation: transfer of cellular hypersensitivity to antigen in vitro.

Authors:  F T Valentine; H S Lawrence
Journal:  Science       Date:  1969-09-05       Impact factor: 47.728

7.  Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.

Authors:  J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1966-07       Impact factor: 11.205

8.  Synthesis of macrophage migration inhibition factor (MIF) by immunoglobulin-producing lymphocyte lines and their clones.

Authors:  T Tsuchimoto; D G Tubergen; A D Bloom
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

9.  Production and characterization of migration inhibitory factor(s) (MIF) of established lymphoid and non-lymphoid cell lines.

Authors:  P S Papageorgiou; W L Henley; P R Glade
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

10.  The Wiskott-Aldrich syndrome. Results of transfer factor therapy.

Authors:  L E Spitler; A S Levin; D P Stites; H H Fudenberg; B Pirofsky; C S August; E R Stiehm; W H Hitzig; R A Gatti
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

View more
  64 in total

1.  Inflammatory mediators in culture filtrates of Escherichia coli.

Authors:  T Yoshida; S Cohen; P E Bigazzi; T Kurasuji; A Amsden
Journal:  Am J Pathol       Date:  1975-11       Impact factor: 4.307

Review 2.  Immunity to mycoplasma infections of the respiratory tract: a review.

Authors:  G Taylor
Journal:  J R Soc Med       Date:  1979-07       Impact factor: 5.344

3.  Mediation of macrophage effector function by lymphokine.

Authors:  L W Poulter; J L Turk
Journal:  Agents Actions       Date:  1976-02

4.  Thrombocyte migration and the release of thrombocyte inhibitory factor (ThrIF) by T and B cells in the chicken.

Authors:  R S Stinson; M M Mashaly; B Glick
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

5.  Immunopathology of the lung: a review.

Authors:  K J Johnson; W E Chapman; P A Ward
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

6.  Biologic and antigenic similarity of virus-induced migration inhibition factor to conventional, lymphocyte-derived migration inhibition factor.

Authors:  T Yoshida; P Bigazzi; S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

7.  Cell-mediated immunity to gluten within the small intestinal mucosa in coeliac disease.

Authors:  P D Howdle; A W Bullen; M S Losowsky
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

8.  In vivo and in vitro cell-mediated immune responses to a cell wall antigen of Blastomyces dermatitidis.

Authors:  F Deighton; R A Cox; N K Hall; H W Larsh
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

9.  Effect of pretreatment with Bacillus Calmette-Guerin on the course of a Listeria monocytogenes infection in normal and congenitally athymic (nude) mice.

Authors:  E J Ruitenberg; L M Van Noorle Jansen; W Kruizinga; P A Steerenberg
Journal:  Br J Exp Pathol       Date:  1976-06

10.  In vitro production and cellular origin of murine type II interferon.

Authors:  G Sonnenfeld; A D Mandel; T C Merigan
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.